These materials are available for nonprofit educational use. This repository is allowed by copyright disclaimer under title 17, Appendix E, section 107 of the United States Copyright Act. Under this statute, allowance is made for “fair use” for purposes such as criticism, comment, news reporting, teaching, scholarship, and research. As defined, fair use specifically applies to this repository.
A range of barrier materials have been reported as a potential disease modifying adjunct to fasciectomy.
- Abbott AC. Dupuytren’s Contraction: A Review of the Literature and a Report of a New Technique in Surgical Treatment. A Preliminary Statement. Can Med Assoc J 1929;20:250–3. (PDF)
- Degreef I, De Smet L. Cellulose Implants in Dupuytren’s Surgery. In: Eaton C, Seegenschmeidt MH, Bayat A, Gabbiani G, Werker P, Wach W, editors. Dupuytren’s Dis. Relat. Hyperproliferative Disord., Berlin Heidelberg: Springer; 2012, p. 207–11. (PDF)
- Degreef I, Tejpar S, De Smet L. Improved postoperative outcome of segmental fasciectomy in Dupuytren disease by insertion of an absorbable cellulose implant . J Plast Surg Hand Surg 2011; 45 :64–157. (PDF)
- Terry MJ, Sue GR, Goldberg C, Narayan D. Hueston Revisited: Use of Acellular Dermal Matrix Following Fasciectomy for the Treatment of Dupuytren’s Disease. Ann Plast Surg 2014;72:2–4. (PDF)
- Hovius SER, Kan HJ, Smit X, Selles RW, Cardoso E, Khouri RK. Extensive percutaneous aponeurotomy and lipografting: a new treatment for Dupuytren disease. Plast Reconstr Surg 2011;128:221–8. (PDF)
- Khouri RK, Smit JM, Cardoso E, Pallua N, Lantieri L, Mathijssen IMJ, et al. Percutaneous aponeurotomy and lipofilling: a regenerative alternative to flap reconstruction? Plast Reconstr Surg 2013;132:1280–90. (PDF)
- Verhoekx JSN, Mudera V, Walbeehm ET, Hovius SER. Adipose-derived stem cells inhibit the contractile myofibroblast in Dupuytren’s disease. Plast Reconstr Surg 2013;132:1139–48. (PDF)